AFAM Capital’s Zimmer Biomet ZBH Stock Holding History

AFAM Capital’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	$6.34M	Buy	49,708 +1,640	+3%	+$195K	0.88%	39
2018 Q2	$5.2M	Sell	48,068 -528	-1%	-$57.5K	0.76%	59
2018 Q1	$5.14M	Buy	48,596 +902	+2%	+$105K	0.57%	83
2017 Q4	$5.59M	Buy	47,694 +203	+0.4%	+$23K	0.62%	73
2017 Q3	$5.4M	Buy	47,491 +1,729	+4%	+$200K	0.65%	66
2017 Q2	$5.71M	Buy	45,762 +3,404	+8%	+$404K	0.73%	52
2017 Q1	$5.02M	Buy	+42,358	New	+$4.8M	0.7%	63

Other funds holding ZBH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

AFAM Capital's ZBH Position: Q3 2018 in Review

AFAM Capital increased its Zimmer Biomet (ZBH) stake by 3.4% in Q3 2018, buying an estimated $195K and bringing the position to 49,708 shares worth $6.34M. The position accounts for 0.88% of the portfolio, ranked #39.

AFAM Capital first reported a position in ZBH in Q1 2017 and has held it in 7 quarters since. 891 funds tracked by Wall St. Rank hold ZBH as of Q3 2018.

AFAM Capital held 49,708 shares of Zimmer Biomet worth $6.34M as of Q3 2018.
AFAM Capital bought 1,640 Zimmer Biomet shares in Q3 2018, an estimated $195K.
Zimmer Biomet made up 0.88% of AFAM Capital's portfolio in Q3 2018, its #39 holding.
AFAM Capital first reported a position in Zimmer Biomet in Q1 2017 and has held it in 7 quarters since.
891 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2018.

Based on AFAM Capital's 13F filing for Q3 2018, filed 14 Nov 2018.